Results 221 to 230 of about 6,006,054 (377)

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Microstructural-Mechanical Interactions of Drug Coated Balloons

open access: green, 2019
Jesse Lauber   +3 more
openalex   +2 more sources

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

open access: yesMolecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

A Dose-Aware Model for Revealing Dose-Risk Relationship of Drug-Drug Interaction. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol
Shi Y   +8 more
europepmc   +1 more source

Drug-drug interaction between TAS-303 and simvastatin/midazolam in healthy subjects

open access: diamond, 2018
Yuji Kumagai   +8 more
openalex   +2 more sources

P171 Drug-drug interactions in hiv patients taking pharmacokinetic enhancers [PDF]

open access: bronze, 2017
Rachel MacCann   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy